Toggle SGML Header (+)


Section 1: 8-K (8-K)

Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 6, 2019 (May 6, 2019)

National Health Investors, Inc.
(Exact name of Registrant as specified in its charter)


 
Maryland
001-10822
62-1470956
 
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
 

222 Robert Rose Drive
Murfreesboro, Tennessee 37129
(Address of principal executive offices)

(615) 890-9100
(Registrant's telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year,
if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
NHI
New York Stock Exchange






Item 7.01. Regulation FD Disclosure.

The Company is furnishing its Supplemental Information for the quarter ended March 31, 2019, which is also contained on its website (www.nhireit.com). See Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

Exhibit Index

Number
 
Exhibit
99.1
 
 
 
 
99.2
 

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

National Health Investors, Inc.



By: /s/ Roger R. Hopkins
Name: Roger R. Hopkins
Title: Chief Accounting Officer



Date: May 6, 2019



(Back To Top)

Section 2: EX-99.1 (SUPPLEMENTAL INFORMATION, HTML FORMAT)

Exhibit


397826873_q119page01.jpg








397826873_q119page02.jpg








397826873_q119page03.jpg








397826873_q119page04.jpg








397826873_q119page05.jpg








397826873_q119page06.jpg








397826873_q119page07.jpg








397826873_q119page08.jpg








397826873_q119page09.jpg








397826873_q119page10.jpg








397826873_q119page11.jpg








397826873_q119page12.jpg









397826873_q119page13.jpg








397826873_q119page14.jpg








397826873_q119page15.jpg








397826873_q119page16.jpg








397826873_q119page17.jpg








397826873_q119page18.jpg








397826873_q119page19.jpg








397826873_q119page20.jpg


(Back To Top)

Section 3: EX-99.2 (SUPPLEMENTAL INFORMATION, PDF FORMAT)

Click here to view PDF

Note: This PDF document represents an unofficial copy of information contained within this document, as allowed by the recent EDGAR system modernization.
SNL Interactive cannot take responsibility for the integrity of this file or its appearance, layout, or legibility. It is provided as is by the filer of this document.

(Back To Top)